Fudan University
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Private
- Established
- 1905-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.fudan.edu.cn
Adjuvant IFN-α for Patients Underwent Curative Surgery for HCC With a Low miR-26 Expression
Phase 3
- Conditions
- Hepatocellular Carcinoma
- Interventions
- Drug: interferon-alpha (IFN-alpha)
- First Posted Date
- 2012-09-10
- Last Posted Date
- 2018-06-01
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 296
- Registration Number
- NCT01681446
- Locations
- 🇨🇳
The Mengchao hepatobiliary hospital，Fujian Medical University，and Liver disease research center of Fujian province, Fuzhou, Fujian, China
🇨🇳Zhongshan Hospital, Xiamen University, Xiamen, Fujian, China
🇨🇳Liver Cancer Institute and Zhongshan Hospital, Fudan University, Shanghai, Shanghai, China
The Clinical Trail Of NAFLD Treated By Traditional Chinese Medicine
Phase 1
Completed
- Conditions
- NAFLD( Non-alcoholic Fatty Liver Disease )
- Interventions
- Drug: Chinese herb (YiQiSanJu)
- First Posted Date
- 2012-09-03
- Last Posted Date
- 2012-09-05
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 40
- Registration Number
- NCT01677325
Detection and Enumeration of Circulating Tumor Cells in Rectal Cancer
- Conditions
- Rectal Cancer
- Interventions
- Radiation: radiation therapy
- First Posted Date
- 2012-08-24
- Last Posted Date
- 2012-08-24
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 100
- Registration Number
- NCT01671891
- Locations
- 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, China
Radiotherapy Followed by Adjuvant Chemotherapy in NK/T-cell Lymphoma
Phase 2
- Conditions
- Extranodal NK/T-cell Lymphoma, Nasal Type
- Interventions
- Drug: Radiotherapy followed by chemotherapy
- First Posted Date
- 2012-08-17
- Last Posted Date
- 2013-03-05
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 30
- Registration Number
- NCT01667302
- Locations
- 🇨🇳
Fudan University Cancer Hospital, SHanghai, Shanghai, China
Radiotherapy Alone Versus Concurrent Chemoradiation in Low Risk NK/T-cell Lymphoma
Phase 2
Terminated
- Conditions
- Extranodal NK/T-cell Lymphoma, Nasal Type
- Interventions
- Radiation: Radiotherapy aloneDrug: Concurrent chemoradiation
- First Posted Date
- 2012-08-17
- Last Posted Date
- 2013-03-05
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 4
- Registration Number
- NCT01667289
- Locations
- 🇨🇳
Fudan University Cancer Hospital, Shanghai, Shanghai, China
Bevacizumab Plus Modified FOLFOX6 Regimen as the Salvage Treatment in Metastatic Breast Cancer (MBC) Patients
- First Posted Date
- 2012-08-06
- Last Posted Date
- 2015-09-09
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 72
- Registration Number
- NCT01658033
- Locations
- 🇨🇳
Fudan University Cancer Hospital, Shanghai, Shanghai, China
A Trial Comparing S1 Generic With Capecitabine in Metastatic Breast Cancer (MBC)
- First Posted Date
- 2012-08-02
- Last Posted Date
- 2018-01-23
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 386
- Registration Number
- NCT01655992
- Locations
- 🇨🇳
Fudan University Cancer Hospital, Shanghai, Shanghai, China
A Study of Famitinib Malate in HER2-negative Metastatic Breast Cancer
- First Posted Date
- 2012-07-31
- Last Posted Date
- 2013-12-03
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 28
- Registration Number
- NCT01653574
- Locations
- 🇨🇳
Fudan University Cancer Hospital, Shanghai, Shanghai, China
A Study of Apatinib in Non-triple-negative Metastatic Breast Cancer
- First Posted Date
- 2012-07-31
- Last Posted Date
- 2013-12-03
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 20
- Registration Number
- NCT01653561
- Locations
- 🇨🇳
Fudan University Cancer Hospital, Shanghai, China
Induction Chemotherapy Followed by Concurrent Radiation With Cetuximab or Cisplatin in Locally Advanced Nasopharyngeal Cancer
Phase 2
- Conditions
- Nasopharyngeal Carcinoma
- Interventions
- First Posted Date
- 2012-06-08
- Last Posted Date
- 2012-06-08
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 46
- Registration Number
- NCT01614938
- Locations
- 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China
© Copyright 2025. All Rights Reserved by MedPath